J.P. Morgan Securities discloses Kangji Medical share dealings

A public disclosure form from the Securities and Futures Commission on October 6, 2025, detailed J.P. Morgan Securities PLC's dealings in Kangji Medical Holdings Limited shares. This activity occurred in the context of a privatization via a scheme of arrangement. The transactions, made on October 3, 2025, involved purchases of "Other types of securities (e.g. equity swaps)" for hedging Delta 1 products arising from unsolicited client-driven orders.

J.P. Morgan Securities PLC executed two purchase transactions. One involved 32,000 shares for a total of $286,183.87, with prices ranging from a high of $8.95 to a low of $8.87 per share. The second transaction was for 1,000 shares, totaling $8,935.64, with prices between $8.93 and $8.92 per share.

J.P. Morgan Securities PLC is identified as a Class (5) associate connected with the Offeror and ultimately owned by JPMorgan Chase & Co. The dealings were conducted for its own account.